To test the efficacy of the selective HDAC6 inhibitor ITF3756 in colon cancer cells, we first evaluated its effects on cell viability and morphology in HCT116 and HT29 CRC cell lines. This evidence concerns the gene HDAC6 and colorectal carcinoma.